Introduction
Cardiovascular disease remains a considerable medical and socio-economic health problem since in the United States alone, each year over half a million people die of heart attacks or the consequences thereof. 1 Autopsy studies have shown that 68% of all myocardial infarctions are associated with lesions of less than 50% severity. [2] [3] [4] [5] This means that small, non-obstructive and haemodynamically insigni®cant atherosclerotic plaques appear to be responsible for sudden death due to acute vessel closure and subsequent myocardial infarction. Today, interventional cardiologists do not tackle these potentially high-risk plaques for several reasons. First, there is no technique available today to identify the highrisk plaque. Second, it is unknown which of those plaques are harmful (leading to rupture) as not all plaques show an equally high risk of rupture. Furthermore, current standard technology such as coronary angiography is not able to predict the likelihood of rupture of such plaques, as it is also unable to visualize the plaques with reasonable speci®city. Intravascular ultrasound (IVUS) as a means to interrogate the plaque may offer an attractive alternative, but until now, has not been able to predict coronary events. Since early detection is crucial, it is important that other techniques are
The percutaneous assessment of regional and acute coronary hot unstable plaques by thermographic evaluation (PARACHUTE) study: a prospective reproducibility and prognostic clinical study using thermography to predict future ischemic cardiac events 6 . For the non-invasive detection, multislice computer tomography and magnetic resonance tomography are currently the front-runners. They offer the advantage of being non-invasive but have the disadvantages of low resolution, cardiac motion artifacts, and inability of analyzing distal segments of coronary arteries as well as being expensive. Invasive techniques may be disadvantageous because of their invasive approach, but on the other hand, these are capable of alleviating the problems seen by non-invasive techniques. Among the potential candidates for invasive techniques, there is thermography, optical coherence tomography, near-infrared spectroscopy, elastographypalpography and high-resolution intravascular ultrasound [7] [8] [9] [10] [11] . Several groups, including ours have reported on the possibility of using intravascular thermography to detect temperature heterogeneity, both in experimental conditions as well as in humans [7] [8] 12, 13 . The experiments, both in animals and in humans, have shown that temperature heterogeneity is associated with presence of macrophages and that is predominantly present in patients with acute myocardial infarction and unstable angina. Temperature heterogeneity has been associated with in¯ammation, an important feature of the high-risk plaque, and it has been linked to clinical syndromes. We have designed the Percutaneous Assessment of Regional Acute Coronary Hot Unstable plaques by Thermographic Evaluation (PARACHUTE) study to try to ®nd an answer to the following questions. What is the prognostic value of non-obstructive plaques with temperature heterogeneity? Can thermography indeed predict ischemic events? How heterogeneous are acute ruptured plaques? Does in¯ammation, represented by temperature differences, play a role in the vulnerability of a plaque? The de®nition of a new concept (de®ned as thermal burden) is introduced and described in the Objectives.
The PARACHUTE clinical study and population
The PARACHUTE study is a multi-centre, prospective, observational cohort study designed to assess, the reproducibility, and prognostic value of intravascular thermography. The aim of this study is to assess the value of thermography using the ThermoSense 2 catheter (Guildford, UK) in the prognosis of ischemic cardiac events (ICE) and its components (death, myocardial infarction [MI] , and coronary artery bypass grafting and repeat percutaneous transluminal coronary angioplasty) as well as hospitalisation for ischemia and/or anginal symptoms. The study population consists of patients presenting with an acute coronary syndrome within the last two weeks or an acute MI having elevated troponin above the upper limit of normal or unstable angina (Braunwald class I-III B and C). Inclusion and exclusion criteria are shown in Table 1 .
Objectives
The primary objective of the study is the predictive value of temperature heterogeneity towards the occurrence of ICE and hospitalisation for ischemia and/or anginal symptoms. Secondary objectives are the predictive value of high-risk plaques associated with the development of future cardiac events, the assessment of safety of the thermography procedure during initial hospitalisation, the assessment of temperature reproducibility and heterogeneity in coronary arteries, the predictive value of a different set of thermographic parameters towards the occurrence of any cardiac event. These thermographic parameters ( Figure 1 ) are vessel thermographic burden (VTB or total area under the curve of all temperature increases measured for a particular vessel); normalized vessel thermographic burden (nVTB, or total area under the curve of all temperature increases measured for a particular vessel, normalized for the lowest value found); total thermographic burden (TTB, or total area under the curve of all temperature increases measured); normalized total thermographic burden (nTTB, or total area under the curve of all temperature increases measured, normalized for the lowest value found), all the above measures, averaged per cm of vessel (aVTB, anVTB, aTTB, anTTB). All the above measures will be performed not only with the mean temperature curve (derived from all four thermistors) but also with all independent temperature curves (including the curve that shows the highest temperature readings).
Thermal burden is a new theoretical concept that is trying to re¯ect a global assessment of temperature heterogeneity within the whole coronary artery tree or at least the analyzed segment. By interrogating the analyzed segment, thermal burden is expected to provide information on the in¯ammatory processes within the artery, a feature coinciding with plaque/clinical instability. By analyzing all three vessels, when possible (see Design), patients with single-vessel disease may serve as controls.
Design
A total of 260 patients with acute MI and elevated troponin above the upper limit of normal ful®lling all inclusion/exclusion criteria, will be included.
An attempt should be made to investigate all three main epicardiac vessels with the thermography catheter at baseline after PCI of the¯ow limiting vessel(s). Offline quantitative coronary angiography (QCA) will be assessed of all three vessels. After thermography, patients will be monitored closely until they leave the hospital. At one, six and 12 months, a clinical follow-up visit will be scheduled. At 12 months follow-up, angiography and thermography of the vessel showing the highest thermo-70 S Verheye, G Van Langenhove, G-A van Es and P W Serruys graphic burden at baseline will be performed ( Table 2) . If more than one vessel has the same value for thermographic burden, one vessel will be selected at the discretion of the investigator. In addition, there will be four small subgroups of patients to: Independent core laboratories (Cardialysis, The Netherlands) will assess angiographic/ IVUS outcomes and a clinical endpoint committee will assess clinical events.
The pullback of the catheter has to start from the indicated locations, differing per vessel: from the bifurcation posterior descending artery with the distal right of the right coronary artery, from the bifurcation second diagonal branch with the left anterior descending artery and from the bifurcation postero-lateral branch with the distal circum¯ex artery. If there is an intermediate branch (>2.5 mm), then a 30 mm pullback will be performed.
Statistics
Overall event rates of death and MI at one year are expected to be about 10%. 14, 15 In order to distinguish the prognostic value of thermography, as assessed by average thermographic burden, 224 eligible patients are required to distinguish an Odds Ratio of 1.8 (=16.7% risk at m ) with a power of 80% and a 1-sided type I error rate of 5%, testing the null-hypothesis that the covariate (some measure of thermographic burden or temperature) has no in¯uence on the prediction of endpoint events (b = 0) against the one-sided alternative hypothesis (b > 0), using the Wald test in a logistic No Vulnerable Plaque (VP) in other vessels should be stented: General and clinical criteria a. Patients of both sexes, more than 18 years old, with typical symptoms of acute myocardial infarction and positive troponin. b. Patients eligible for a diagnostic angiogram and coronary revascularization in native coronary artery/arteries. c. Willing and able to comply with the speci®ed follow-up evaluation. d. Written informed consent obtained. e. The target vessel(s) must be suitable for investigation with the thermography catheter as assessed by on-line QCA. The target vessel(s) must be a major coronary artery or major branch. f. The subject must be an acceptable candidate for CABG. Exclusion criteria General and clinical criteria a. Braunwald class IA, IIA, IIIA (unstable angina caused by non-cardiac illness). b. Known allergies to aspirin, clopidogrel bisulfate, ticlopidine, heparin, stainless steel, copper or a sensitivity to contrast media which cannot be adequately pre-medicated. c. Previous participation in this study or participation in another study with any investigational drug or device within the past 30 days (study participation ends after completion of the ®nal follow-up). d. Life expectancy of less than one year or factors making clinical and/or angiographic follow-up dif®cult. e. Previous or planned CABG. f. Planned major surgery. g. Impaired renal function (creatinine >2 mg/dl or !150 mmol/L). h. The subject has a history of bleeding diathesis or coagulopathy. i. The subject suffered a stroke within the past year. j. Coronary intervention within the last six months. Criteria related to angioplasty a. Left main coronary disease with !50% stenosis. b. Minimal luminal diameter <2 mm in the segments to be analyzed. c. Angiographic evidence of thrombus that cannot be resolved by therapy, occupying !50% of the target vessel segment diameter. d. Ejection fraction 30%. e. Previous bifurcation stenting in the segment(s) to be analyzed. f. The proximal vessel is moderately to severely tortuous (moderate: two bends > 75°or one bend > 90°) in the segment(s) to be analyzed. g. History of coronary vasospasm. h. Presence of overlapping stents in segment(s) to be analyzed. i. Planned stenting of vulnerable non-obstructive plaques. j. Presence of chronic total occlusion in side branch. The safety population will consist of all patients who signed the informed consent. The primary analysis population will consist of all patients who signed the informed consent, had a (partially) successful thermography of all three vessels and who were discharged from the hospital. Additional analysis will be performed (1) per lesion; (2) correlating baseline and follow-up thermography; (3) reproducibility; (4) correlating IVUS and thermography; and (5) correlating events with location of high/low temperature. For these analyses, prede®ned subsets of the primary analysis population will be used.
For the prognostic analysis of thermography only events will be counted, which occurred after hospital discharge and before one-year angiographic follow-up. Count variables will be presented as a rate with its 95% con®dence interval, whenever appropriate. Continuous variables will be presented as means and standard deviations with their 95% con®dence interval, whenever appropriate. Differences (with respect to patient characteristics and thermographic parameters at baseline) between subgroups of patients will be evaluated by unpaired Student's t test. Both univariable and multivariable logistic regression analysis will be performed to study the diagnostic value of thermographic measurements to predict recurrence of symptoms at 12 months. Secondary analysis using multivariate Cox regression method will be performed 16 . This study will also explore Figure 1 Figure showing a set of thermographic parameters used towards the occurrence of any cardiac event. These parameters are: (A) vessel thermographic burden (VTB or total area under the curve of all temperature increases measured for a particular vessel), normalized vessel thermographic burden (nVTB or total area under the curve of all temperature increases measured for a particular vessel, normalized for the lowest value found), vessel thermographic burden (VTB) averaged per cm of vessel (aVTB), and normalized vessel thermographic burden (nVTB) averaged per cm of vessel (anVTB); after analyzing all vessels (B), the following parameters are: (C) total thermographic burden (TTB or total area under the curve of all temperature increases measured), normalized total thermographic burden (nTTB or total area under the curve of all temperature increases measured, normalized for the lowest value found), total thermographic burden (TTB) averaged per cm of vessel (aTTB), and normalized total thermographic burden (nTTB) averaged per cm of vessel (anTTB). All the above measures will be performed with the mean temperature curve (mean from all four thermistors) and with all independent temperature curves (derived from each thermistor; including the curve that shows the highest temperature readings); 0 = the values at start of the procedure, 0' = minimum value (as per de®nition of 1-sided analysis).
S Verheye, G Van Langenhove, G-A van Es and P W Serruys
a possible`prognostic threshold': a cut-point in the range such that any value at or above that point would be considered as positive (i.e. characteristic of an event) and any value below as negative. Sensitivity (percent of patients with an event that does exceed the thresholdor true positive probability) and speci®city (percent of event-free patients that does not exceed the thresholdor true negative probability) are calculated at each threshold. ROC curves will also be constructed, and the area under the ROC curve will be reported, representing the diagnostic power of the variable at hand (range, 50-100%). The pre-selected optimal threshold of a signi®-cant predictive variable will be de®ned as the maximum of the sum of sensitivity and speci®city. With the help of this threshold, the population will be divided in two categories. The frequency of events in both categories will be determined and differences will be evaluated by w 2 analysis. Relative risks will be reported.
Discussion
The main goal of this trial is to predict occurrence of ischemic cardiac events based on the measured temperature heterogeneity in patients presenting with acute coronary syndromes. Secondary objectives are the predictive value of high-risk plaques associated with the development of future cardiac events, the assessment of safety of the thermography procedure during initial hospitalisation, the assessment of temperature reproducibility and heterogeneity in coronary arteries, and the predictive value of a different set of thermographic parameters towards the occurrence of any cardiac event.
New imaging modalities to detect vulnerable plaque should be designed to evaluate prospectively the natural course of plaques, i.e. to detect lesions at increased risk for rupture at an early stage prior to resulting in a coronary event. So far, there have been reports on the safety and feasibility use of several imaging techniques; however, none has addressed the predictive value of such test in patients presenting with acute coronary syndromes towards future events. The vulnerable plaque is de®ned as a plaque that is not stenotic but with a high likelihood of becoming disrupted, thereby forming a thrombogenic focus after exposure to an acute risk factor 17 . Several factors may play a role in the propensity for rupture, but plaque composition is undoubtedly important. The histopathological correlate of the vulnerable plaque is a plaque with a lipid pool and a necrotic core, with a thin ®brous cap (between 65 and 150 mm), in®ltrated by macrophages 18 . Although any plaque may rupture, the plaques that are prone to rupture have been associated with a high tensile mechanical stress within such a thin ®brous cap and a large lipid and necrotic core. None the less, not only cap thickness and mechanical forces help determining the potential to withstand the stress but also the composition of the cap: mechanical stress at the start of fracture of the ®brous caps is decreased when the cap contains macrophages 19 . This ®nding was underscored in a report by van der Wal et al., in which the authors demonstrated that the underlying morphology of complex atherosclerotic lesions leading to acute coronary syndromes and acute myocardial infarction is heterogeneous with respect to both plaque architecture and cellular composition 20 . At sites of rupture, the authors found a high in¯ammatory response with an increased number of macrophages. The presence of macrophages suggests an in¯ammatory reaction. Indeed, atherosclerosis is an in¯ammatory disease and numerous factors may play a role in the induction and promotion of in¯ammation involving several cells including endothelial cells, monocytes as well as T-cells and their molecular and chemical end products as well as ow variations (shear stress) 5, [21] [22] [23] [24] . The production of matrix metalloproteinases, tissue factor and other sub-stances released by apoptotic macrophages is found to be associated with plaque rupture and thrombosis 25 . We, therefore, think that intravascular thermography may offer a solution in identifying those lesions or patients at increased risk, as temperature heterogeneity is linked to in¯ammation.
The patients to be enrolled in this study are patients presenting with an acute coronary syndrome and thus, already experiencing thrombus formation probably associated with a vulnerable plaque. These patients show a high likelihood of having an increased event rate in the following year. In addition, it is known that these patients tend to have more than one vulnerable plaque 18, 26, 27 . Although this clinical study using an invasive technique to detect temperature heterogeneity in this speci®c patient population may be useful and provide additional value to the ®eld of cardiology, we realize that until such results are available, both its feasibility and value will be dif®cult to assess.
In addition, de®ning a new concept of thermographic burden as a tool to predict the occurrence of future ischemic events is introduced.
Thermal burden may provide a global assessment of temperature heterogeneity within the whole coronary artery tree. We feel that thermal burden may contribute more to the understanding of the pathophysiology of the vulnerable atherosclerotic plaque than peak temperature, which may be obtained at one single, randomly chosen spot within the plaque. 8 Since coronary artery disease is an in¯ammatory disease, global coronary approach (assessing all three vessels) may be helpful in detecting the total`vulnerable' burden of the vessel. As thermal burden speci®cally interrogates the whole segment, it may parallel the widespread in¯ammation that coincides with plaque/clinical instability. Demonstrating that thermal burden may have a prognostic value in predicting future events in patients demonstrating temperature heterogeneity is pursued in this study.
